Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 271

Showing 1-25 of 271 citing articles:

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Tianyang Mao, Benjamin Israelow, Mario A. Peña-Hernández, et al.
Science (2022) Vol. 378, Iss. 6622
Open Access | Times Cited: 250
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
Science (2022) Vol. 378, Iss. 6620, pp. 619-627
Open Access | Times Cited: 199
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
Cell Host & Microbe (2023) Vol. 31, Iss. 1, pp. 146-157
Open Access | Times Cited: 132
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 122
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1
Qian Wang, Yicheng Guo, Anthony Bowen, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 3, pp. 315-321.e3
Open Access | Times Cited: 111
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
Joey Ming Er Lim, Anthony T. Tan, Nina Le Bert, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 10
Open Access | Times Cited: 104
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 96
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Renee L. Hajnik, Jessica A. Plante, Yuejin Liang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 662
Open Access | Times Cited: 95
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew, Shubha Talwar, Andy Cross, et al.
EBioMedicine (2022) Vol. 87, pp. 104402-104402
Open Access | Times Cited: 90
Operation Nasal Vaccine—Lightning speed to counter COVID-19
Eric J. Topol, Akiko Iwasaki
Science Immunology (2022) Vol. 7, Iss. 74
Closed Access | Times Cited: 81
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 81
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 74
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 59
Tracking the COVID-19 vaccines: The global landscape
Tushar Yadav, Swatantra Kumar, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 53
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 48
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques
Katherine McMahan, Frank Wegmann, Malika Aïd, et al.
Nature (2023) Vol. 626, Iss. 7998, pp. 385-391
Open Access | Times Cited: 44
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
Qianqian Huang, Yongke Chen, Weiwei Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 519-534
Closed Access | Times Cited: 44
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants
Qian Wang, Yicheng Guo, Anthony Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
BCG immunization induces CX3CR1hi effector memory T cells to provide cross-protection via IFN-γ-mediated trained immunity
Kim A. Tran, Erwan Pernet, Mina Sadeghi, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 418-431
Closed Access | Times Cited: 30
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 21
Opportunities and challenges for T cell-based influenza vaccines
Tim R. Mosmann, Andrew J. McMichael, Alexandre LeVert, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 10, pp. 736-752
Closed Access | Times Cited: 21
Programmable Macrophage Vesicle Based Bionic Self‐Adjuvanting Vaccine for Immunization against Monkeypox Virus
Weiqiang Lin, Chenguang Shen, Mengjun Li, et al.
Advanced Science (2024)
Open Access | Times Cited: 20
Exploring new perspectives in immunology
Ruslan Medzhitov, Akiko Iwasaki
Cell (2024) Vol. 187, Iss. 9, pp. 2079-2094
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top